Long-term use and cost-effectiveness of secondary prevention drugs for heart disease in Western Australian seniors (WAMACH): a study protocol

INTRODUCTION: Secondary prevention drugs for cardiac disease have been demonstrated by clinical trials to be effective in reducing future cardiovascular and mortality events (WAMACH is the Western Australian Medication Adherence and Costs in Heart disease study). Hence, most countries have adopted h...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Gunnell, Anthony S, Knuiman, Matthew W, Geelhoed, Elizabeth, Hobbs, Michael S T, Katzenellenbogen, Judith M, Hung, Joseph, Rankin, Jamie M, Nedkoff, Lee, Briffa, Thomas G, Ortiz, Michael, Gillies, Malcolm, Cordingley, Anne, Messer, Mitch, Gardner, Christian, Lopez, Derrick, Atkins, Emily, Mai, Qun, Sanfilippo, Frank M
Format: Artigo
Langue:Inglês
Publié: BMJ Publishing Group 2014
Sujets:
Cardiovascular Medicine
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4170208/
https://ncbi.nlm.nih.gov/pubmed/25234510
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2014-006258
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires